Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Catalio Capital Management, LP
Form 13F · Q2 2026

Catalio Capital Management, LP

CIK 1958125申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$5.3亿
申报组合市值
39
持仓数量
7
Quarters on record
Top 50
持仓数量

Catalio Capital Management, LP——持仓

共 39 个持仓中的前 39 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1AVLN Avalyn Pharmaceuticals Inc1.7M—$5517万10.4%
2JNJ Johnson & Johnson138,946—$3529万6.6%
3GILD Gilead Sciences Inc269,309+64.3%$3402万6.4%
4BBIO Bridgebio Pharma Inc455,041+5.3%$3389万6.4%
5SNDX Syndax Pharmaceuticals Inc1.2M+16.5%$2658万5.0%
6DFTX Definium Therapeutics Inc562,672−45.8%$2647万5.0%
7BMY Bristol-Myers Squibb Co412,961−1.8%$2379万4.5%
8PBLS Parabilis Medicines Inc824,043—$2255万4.2%
9NTRA Natera Inc82,181+15.9%$2231万4.2%
10INCY Incyte Corp191,627+5.2%$2172万4.1%
11SEPN Septerna Inc536,152+82.1%$1796万3.4%
12MLYS Mineralys Therapeutics Inc648,722+47.8%$1750万3.3%
13HTFL Heartflow Inc583,055+44.5%$1711万3.2%
14CRVS Corvus Pharmaceuticals Inc1.1M+21.2%$1615万3.0%
15GPCR Structure Therapeutics Inc276,550+8.3%$1484万2.8%
16PTGX Protagonist Therapeutics Inc106,799—$1309万2.5%
17IRON Disc Medicine Inc159,384+29.6%$1166万2.2%
18EW Edwards Lifesciences Corp124,778−13.7%$1129万2.1%
19AXSM Axsome Therapeutics Inc.43,182—$1057万2.0%
20RARE Ultragenyx Pharmaceutical In316,252−62.8%$1056万2.0%
21KLRA Kailera Therapeutics Inc468,750—$1033万1.9%
22KPTIQ Karyopharm Therapeutics Inc940,855+4.8%$919万1.7%
23ODTX Odyssey Therapeutics Inc457,839—$857万1.6%
24ASND Ascendis Pharma A/S31,759—$847万1.6%
25KARD Kardigan Inc312,500—$745万1.4%
26ELDN Eledon Pharmaceuticals Inc1.7M+3.4%$668万1.3%
27FDMT 4D Molecular Therapeutics In471,254—$627万1.2%
28MANE Veradermics Inc45,856−73.6%$564万1.1%
29DYN Dyne Therapeutics Inc244,929−13.4%$544万1.0%
30GUTS Fractyl Health Inc6.2M+12.3%$490万0.9%
31IMCR Immunocore Hldgs Plc148,045+75.5%$470万0.9%
32DNTH Dianthus Therapeutics Inc32,941−94.1%$321万0.6%
33BBOT Bridgebio Oncology Therapeut318,407—$243万0.5%
34TARA Protara Therapeutics Inc520,148−10.3%$199万0.4%
35HYPR Hyperfine Inc1.3M+0.0%$178万0.3%
36ATAIBECKLEY INC Ataibeckley Inc196,858+0.0%$104万0.2%
37MGX Metagenomi Therapeutics Inc528,993+0.0%$63万0.1%
38OM Outset Med Inc118,279+0.0%$51万0.1%
39FTH Faeth Therapeutics Inc14,718+0.0%$37万0.1%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。